PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Fusion Public Relations, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Microsoft Research Sponsors BioMed Central 2007 Research Awards - BioMed Central, the world’s largest publisher of peer-reviewed, open access research journals, is pleased to announce that Microsoft Research has agreed to be the premium sponsor of the BioMed Central Research Awards for 2007 - BioMedCentral.com
Microsoft Research Sponsors BioMed Central 2007 Research Awards

 

NewswireToday - /newswire/ - Bray Maidenhead, Berkshire, United Kingdom, 2007/09/05 - BioMed Central, the world’s largest publisher of peer-reviewed, open access research journals, is pleased to announce that Microsoft Research has agreed to be the premium sponsor of the BioMed Central Research Awards for 2007 - BioMedCentral.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The BioMed Central Research Awards, which began accepting nominations in late July, recognize excellence in research that has been made universally accessible by open access publication in one of the publisher’s 180 journals.

“Microsoft’s External Research group is proud to be a sponsor of the BioMed Central Research Awards and feel it is important to recognize excellence in research,” said Lee Dirks, director, scholarly communications, Microsoft Research. “We are very supportive of the open science movement and recognize that open access publication is an important component of overall scholarly communications.”

Nominations for the awards are now being accepted and will close December 21, 2007. Anyone who publishes original research of major significance in one of BioMed Central’s journals during 2007 is eligible for nomination. Two awards of $5000 (US) will be made — one for biology research, and one for medical research. The winning articles will be selected by a panel including BioMed Central editorial team members and external experts in biology and medicine. Winners will be announced at the BioMed Central Research Awards dinner in early March 2008.

“We’re very pleased that Microsoft Research has shown its commitment to advancing open science by supporting this year’s BioMed Central Research Awards,” said Dr. Matthew Cockerill, BioMed Central's publisher. “With these awards, BioMed Central aims to encourage and reward authors who select BioMed Central journals to publish their very best research.”

The first BioMed Central Research Awards were a great success. The winners were announced at the BioMed Central Open Access Colloquium in February 2007, at the Royal College of Physicians, London.

“Winning a BioMed Central Research Award last year has been a tremendous help with my research,” said Dr. Flavio Zolessi, Professor Adjunto, Universidad de la Republica, Uruguay. “I used the award to purchase equipment and reagents needed for establishing, for the first time in Uruguay, a research line about zebrafish development. Additionally, I have been invited to speak in Uruguay and around South America. This was in due in part to the fact that the paper was published in a very promising open access journal.”

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Fusion Public Relations, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Microsoft Research Sponsors BioMed Central 2007 Research Awards

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Sarah Bedwell - FusionPR.com 
+44(0)16 2850 2601 sarah[.]fusionpr.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Fusion Public Relations, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Fusion Public Relations, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022
FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics
BD to Invest $60 Million in Nebraska Manufacturing Facility
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
Pulse Certified As A Level Four Multichannel Content Agency by Veeva
Earthly Mist - Opioid-Alternative Painkiller, Kratom Now Available in Oklahoma City
MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)